Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.
about
Pairomics, the omics way to mate choiceIdentification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime?Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failureTransplantation immunology: solid organ and bone marrow.Support of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donors.Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1A one-step DNA sequencing strategy to HLA type hematopoietic stem cell donors at recruitment - rethinking typing strategiesOutcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.High throughput HLA genotyping using 454 sequencing and the Fluidigm Access Array™ System for simplified amplicon library preparation.Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.HLA-C expression levels define permissible mismatches in hematopoietic cell transplantationAlternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.Sequence capture and next generation resequencing of the MHC region highlights potential transplantation determinants in HLA identical haematopoietic stem cell transplantationEfficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective StudiesImpact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.What Next? The Next Transit from Biology to Diagnostics: Next Generation Sequencing for Immunogenetics.HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant ResearchThe use of intravenous antibiotics at the onset of neutropenia in patients receiving outpatient-based hematopoietic stem cell transplantsThe effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.Factors associated with hematopoietic cell transplantation (HCT) among patients in a population-based study of myelodysplastic syndrome (MDS) in Minnesota.Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept studyThe impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donorsSignificant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant ResearchAmino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortalityImpact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor.Human leucocyte antigen typing: techniques and technology, a critical appraisal.The role of hematopoietic stem cell transplantation in chronic myeloid leukemia.Fast and accurate HLA typing from short-read next-generation sequence data with xHLA.Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis.Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.In celebration of Ruggero Ceppellini: HLA in transplantation.Regional differences in HLA antigen and haplotype frequency distributions in Germany and their relevance to the optimization of hematopoietic stem cell donor recruitment.
P2860
Q26809970-DCB9A844-32A8-477C-AF78-F69F75678231Q28080914-67B65B13-6AE1-40D4-817E-ADFB5686D5F0Q30414156-9ABFDA6F-DD9E-45DD-9049-4C0AE00145A2Q33642419-84C76A72-B6E8-4981-85C9-511311A9599DQ33665870-B82FE930-707E-44EB-AEE3-EF24DD9E917CQ33747313-F93BEF5E-F647-44C5-BC4B-C66EED1040BCQ33780282-6655D18E-07B5-42DE-A839-743778396F4BQ33803804-77FE28C2-BCC5-4CD4-8CE5-CD03167A71F8Q33916233-5B110A4E-5ABD-402B-93B6-ECA17423DEBAQ34135396-0A50A38B-69CD-4C6F-A90D-0A6A51045A2EQ34303869-256B568C-FF5D-4435-9188-9842ABA96C93Q34310958-4EAAC695-49DC-4815-888B-545C4FD3E776Q34353744-DC1C9FD2-F817-409D-88E4-62F25BFD936CQ34582241-DD26D894-453B-46B1-BB95-0B224F228B9CQ34707280-4E771075-B89D-42A4-85CB-9A41F423E2E8Q34737555-113AD919-71B9-4922-AA52-0835A68B5A48Q35108791-E9A4AA7C-CE60-4B72-AA8F-F5D4FB4AE5A8Q35171759-487B9DC2-4F6E-4DDC-9A50-258CF3E25BC6Q35703480-6FC1313F-1E4D-46FC-978E-0400EC7DE27EQ35958215-F7DC2CAF-FAE3-4203-AEB7-CBF6247B5945Q35998361-5FFFD3B0-B35F-48FC-AAA7-F9606588F5D9Q36055055-06D23C31-8E99-48EB-819E-0FB3F83977EAQ36287292-76AE1193-FE95-4079-8E2C-508DEE4092FCQ36463393-F547FF6E-F844-43B9-B7FC-E9A602F39369Q36499044-E0558865-C043-4187-8B79-6BC75DDD141FQ36545617-3E3BCAAF-1E07-4A89-909E-97EC1CFAFFBEQ36907865-F207ADC7-4807-4A55-9F09-5AF3449C8023Q36951734-7415CCCE-B542-42F3-8EF5-1ED3A1DC7675Q37304135-93234A91-8DA0-4732-9E9B-649ECEFFE108Q37334733-7723456B-5A0B-429B-B69C-872BB4338C3BQ37429693-92B70995-DA2A-4D11-88FD-CE5F9EF5618EQ37555836-13BF7736-2210-4B59-8344-32381A3EC8CBQ37695516-4DD4DDD6-5708-4F95-9427-8FED12B07AF9Q37953441-183E2014-FE94-4860-8B77-6A39C33BEEFCQ38392690-14817A43-3616-4149-8EDD-248366DE5EADQ38695366-8DF9DE91-5DAA-4E1C-9B61-CEC37AB4B3E5Q38721768-574B5D6D-8E23-43E2-A50A-EC66EAF3BAA8Q39067954-693BCD3A-7196-4AC7-9FCD-811D822507A0Q39094693-9C1C79AB-54A8-4309-BA95-7DA76FB57C53Q45392259-2BBE9381-5D8D-4714-83C4-3001EBDC9D4D
P2860
Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in the selection of H ...... Marrow Donor Program Registry.
@en
Advances in the selection of H ...... Marrow Donor Program Registry.
@nl
type
label
Advances in the selection of H ...... Marrow Donor Program Registry.
@en
Advances in the selection of H ...... Marrow Donor Program Registry.
@nl
prefLabel
Advances in the selection of H ...... Marrow Donor Program Registry.
@en
Advances in the selection of H ...... Marrow Donor Program Registry.
@nl
P2093
P1476
Advances in the selection of H ...... Marrow Donor Program Registry.
@en
P2093
Carolyn Katovich Hurley
Effie Petersdorf
Harriet Noreen
Jennifer Ng
Machteld Oudshoorn
Marcelo Fernandez-Viña
Michelle Setterholm
Robert Bray
Robert J Hartzman
Stephen Spellman
P356
10.1016/J.BBMT.2008.05.001
P433
P577
2008-06-20T00:00:00Z